Nathan Bard is a Board of Directors Member at Column Health, Shore Capital's second medication-assisted treatment platform investment. Nate currently leads ATI’s growth function, serving as its Chief Growth Officer. In this role, he is responsible for sales, marketing, mergers, acquisitions, and new clinic growth and openings. Nate joined ATI in 2014, bringing a background in private equity and investment banking experience. Originally from Michigan, Bard is a graduate of the University of Notre Dame with a degree in Finance. With a combination of strategic and financial expertise, Nate has helped ATI expand its acquisition capabilities with an analytical approach to decision making.